Indexé dans
- Ouvrir la porte J
- Clés académiques
- RechercheRef
- Université Hamdard
- EBSCO AZ
- Publions
- Fondation genevoise pour la formation et la recherche médicales
- Google Scholar
Liens utiles
Partager cette page
Dépliant de journal
Revues en libre accès
- Agriculture et aquaculture
- Alimentation et nutrition
- Biochimie
- Bioinformatique et biologie des systèmes
- Business & Management
- Chimie
- Génétique et biologie moléculaire
- Immunologie & Microbiologie
- Ingénierie
- La science des matériaux
- Neurosciences & Psychologie
- Science générale
- Sciences cliniques
- Sciences environnementales
- Sciences médicales
- Sciences pharmaceutiques
- Sciences vétérinaires
- Soins infirmiers et soins de santé
Abstrait
Myocarditis and Pfizer/Biontech bnt162b2 Vaccine Relationship or Coincidence?
Enrique Arturo Lombana Salas
Background: Myocarditis is an inflammation of the cardiac muscle, myocardium, characterized by inflammatory infiltrates and myocardial injury without ischemic cause. Being the viral etiology the main cause. Pfizer’s BNT162b2 vaccine is a formulated lipid nanoparticle that encodes the full-length peak of SARS-CoV-2 Methodology: A narrative review was carried out through various databases from January 2010 to June 2021; the search and selection of articles was carried out in journals indexed in Spanish and English. The following were used as keywords: Myocarditis, Covid-19, BNT162b2, Pfizer. Results: There is a close relationship between the developments of myocarditis after vaccination with Pfizer / BioNTech BNT162b2, as evidenced in different clinical case reports. Taking into account that the comorbidities present in patients can influence its development. Conclusions: The present review offers a relationship between the developments of myocarditis after the PfizerBioNTech BNT162b2 vaccination, as its cause.